Kuperman, D.A., Huang, X., Koth, L.L., Chang, G.H., Dolganov, G.M., Zhu, Z., Elias, J.A., Sheppard, D., and Erle, D.J.: Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma. Nat. Med. 2002, 8:885–889.
Lambrecht, B.N., and Hammad, H.: The role of dendritic and epithelial cells as master regulators of allergic airway inflammation. Lancet 2010, 376:835–843.
Lloyd, C.M., and Hawrylowicz, C.M.: Regulatory T cells in asthma. Immunity 2009, 31:438–449.
Lotvall, J., Akdis, C.A., Bacharier, L.B., Bjermer, L., Casale, T.B., Custovic, A., Lemanske, R.F., Jr., Wardlaw, A.J., Wenzel, S.E., and Greenberger, P.A.: Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome. J. Allergy Clin. Immunol. 2011, 127:355–360.
Meyer, E.H., DeKruyff, R.H., and Umetsu, D.T.: T cells and NKT cells in the pathogenesis of asthma. Annu. Rev. Med. 2008, 59:281–292.
Newcomb, D.C., and Peebles, R.S., Jr.: Th17-mediated inflammation in asthma. Curr. Opin. Immunol. 2013, 25:755-760.
Peebles, R.S. Jr.: The emergence of group 2 innate lymphoid cells in human disease. J. Leukoc. Biol. 2015, 97:469–475.
Robinson, D.S.: Regulatory T cells and asthma. Clin. Exp. Allergy 2009, 39:1314–1323.
Yan, X., Chu, J.-H., Gomez, J., Koenigs, M., Holm, C., He, X., Perez, M.F., Zhao, H., Mane, S., Martinez, F.D., et al.: Non-invasive analysis of the sputum transcriptome discriminates clinical phenotypes of asthma. Am. J. Respir. Crit. Care Med. 2015, 191:1116–1125.
14-12 Allergy to particular foods causes systemic reactions as well as symptoms limited to the gut.
Du Toit, G., Robert, G., Sayre, P.H., Bahnson, H.T., Radulovic, S., Santos, A.D., Brough, H.A., Phippard, D., Basting, M., Feeney, M., et al.: Randomized trial of peanut consumption in infants at risk for peanut allergy. N. Engl. J. Med. 2015, 372:803–813.
Lee, L.A., and Burks, A.W.: Food allergies: prevalence, molecular characterization, and treatment/prevention strategies. Annu. Rev. Nutr. 2006, 26:539–565.
14-13 IgE-mediated allergic disease can be treated by inhibiting the effector pathways that lead to symptoms or by desensitization techniques that aim at restoring biological tolerance to the allergen.
Akdis, C.A., and Akdis, M.: Mechanisms of allergen-specific immunotherapy and immune tolerance to allergens. World Allergy Organ. J. 2015, 8:17.